Karyopharm Therapeutics filed for Chapter 11 bankruptcy as part of a plan to merge with Irish hematology biotech, Ayrmid.
In “Pit Stops with the Peetes,” the couple, who serve as “Gemtesa Go-Getters,” share how the overactive bladder (OAB) drug has helped them return to one of their favorite activities, road trips, ...
Sanofi has predicted that Dupixent will receive “the majority of the benefit” from the direct-to-consumer (DTC) marketing ca ...
Dexcom has also tapped Chris Megino, who has built an online following sharing his journey with type 2 diabetes, and Chelsea ...
The direct-to-patient (DTP) market is full of providers making bold claims. But claims are not outcomes. | The DTP space is ...
Facing looming patent cliffs, AstraZeneca has launched a restructuring initiative aimed at generating $1.5 billion in annual ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results